Related Experiment Video
Updated: Aug 10, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
[CD16+ CD56- indolent, NK cell-lineage granular lymphocyte proliferative disorder with autoimmune hemolytic anemia]
N Tomita1, S Motomura, S Takemura
1Department of Hematology, Yokohama City University Medical Center.
Insights
This rare case highlights a patient with natural killer cell-lineage granular lymphocyte proliferative disorder (NK-GLPD) and autoimmune hemolytic anemia (AIHA). Methylprednisolone showed transient effectiveness in managing both conditions.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Natural killer cell-lineage granular lymphocyte proliferative disorder (NK-GLPD) is a rare hematologic malignancy.
- Autoimmune hemolytic anemia (AIHA) is characterized by autoantibodies against red blood cells.
- The co-occurrence of NK-GLPD and AIHA is exceptionally uncommon.
Observation:
- A 64-year-old male presented with CD16+ CD56- NK-GLPD and Coombs-negative AIHA.
- Initial treatment with intravenous methylprednisolone (1,000 mg for 3 days) provided temporary relief for both conditions.
- Recurrence of AIHA was accompanied by a reappearance of NK-GLPD.
Findings:
- The patient's NK-GLPD and AIHA demonstrated a parallel clinical course.
- Repeated methylprednisolone treatment effectively controlled both the hematologic malignancy and the autoimmune anemia.
Implications:
- This case underscores the potential link between NK-GLPD and autoimmune phenomena.
- It suggests that methylprednisolone may be a viable therapeutic option for managing concurrent NK-GLPD and AIHA.
- Further research is warranted to elucidate the pathogenetic mechanisms underlying this rare association.
Abstract:
A 64-year-old man was given a diagnosis of CD16+ CD56- natural killer cell-lineage granular lymphocyte proliferative disorder (NK-GLPD) with Coombs-negative autoimmune hemolytic anemia (AIHA). Two courses of 1,000 mg intravenous methylprednisolone for 3 days were transiently effective for both AIHA and NK-GLPD. On the recurrence of AIHA, NK-GLPD also re-appeared. The same treatment was effective in controlling both diseases again. This was a rare case of NK-GLPD combined with autoimmune disease.
Related Concept Videos
Lineage Commitment
Cells of the Adaptive Immune Response
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

